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2Abstract
Background
Information is lacking about the severity of complications in children with influenza admitted to
paediatric intensive care units (PICU) in the UK. In this study, we report risk factors for mortality,
invasive ventilation and use of vasoactive drugs for children admitted to PICU with influenza.
Methods
We evaluated all admissions to PICUs in England for resident children with a recorded influenza
diagnosis between September 2003 and March 2015. We used the Paediatric Intensive Care Audit
Network (PICANet) database linked to hospital admission records to identify influenza cases and
high-risk comorbidities among admitted children. We used mixed effects logistic regression models
to determine risk factors for mortality, use of invasive ventilation and vasoactive drugs.
Results
We identified 1961 influenza-related PICU admissions in 1778 children. Children with high-risk
conditions accounted for 1540 admissions (78.5%). The odds of mortality were significantly higher
for girls than boys (adjusted odds ratio 1.91; 95% confidence interval 1.31, 2.79), children from
Asian/Asian British (2.70; 1.74, 4.20) or other minority ethnic groups (3.95; 1.65, 9.42) compared to
white British children, and significantly increased before and during the A(H1N1)pdm 2009 pandemic
compared to the post-pandemic period. Children required invasive ventilation in 1588 admissions
(81.0%), and received vasoactive drugs in 586 admissions (29.9%).
Conclusions
Nearly four fifths of influenza-related PICU admissions occurred in children with high-risk conditions,
highlighting the burden of severe influenza in this vulnerable population Further research is required
to explain sex and ethnic group differences in PICU mortality among children admitted with
influenza.
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3Introduction
Approximately 90 million children less than five years are infected with influenza every year
globally.[1] Influenza infection can lead to a range of physiological effects from mild upper
respiratory symptoms to critical illness including acute respiratory distress syndrome and septic
shock requiring intensive care.[2] The impact of influenza on paediatric intensive care unit (PICU)
capacity was demonstrated during the influenza A(H1N1)pdm2009 pandemic in 2009 and 2010,
when children were more likely to experience severe morbidity and mortality than during seasonal
influenza epidemics.[3, 4] Several multicentre observational studies have highlighted the increased
risk of influenza-related PICU admission in children with chronic conditions.[5-9]
Since September 2013, it has been recommended that all children in the UK aged two years and
older are vaccinated with influenza vaccine every year under a universal programme which is being
progressively rolled out. This replaces a policy of vaccinating only children at high risk of influenza
complications due to the presence of chronic illness. The targeted strategy towards high risk groups
remains for children aged between six months and two years.[10] However, influenza vaccination
uptake in children in England is low. In 2016/17, the proportion of children vaccinated in England
was 19.5% in children between six months and two years and in a high risk group, 34.4% in
preschool children, and 53.6% in six to seven year old schoolchildren.[11, 12] Further, there are no
licensed vaccines for children aged less than six months old, due to a lack of evidence of
effectiveness and concerns about adverse events.[13]
Studies have shown that parents’ views of influenza as a less serious infection may contribute to low
uptake of influenza vaccination in children in the UK.[14, 15] An understanding of risk factors for
poor outcome among children admitted to PICU is needed to identify which children benefit most
from vaccine protection and therefore motivate higher uptake. A mandatory surveillance scheme
was set up by Public Health England in 2011 for reporting the number of laboratory confirmed
influenza admissions to higher dependency (HDU) or intensive care units in the UK.[16] However,
information on risk factors, such as underlying chronic conditions, is only reported for a subset of
admissions.[17]
In this study, we describe characteristics of all children admitted to PICU with influenza in England,
and examine risk factors for mortality. We also examine risk factors for two other markers of illness
severity: invasive ventilation and treatment with vasoactive drugs, and assess whether mortality
and illness severity have changed over time. We use data linkage between PICU and a hospital
admission database to improve the detection of influenza cases and reduce under-recording of high-
risk chronic conditions.
Materials and methods
Data sources
The Paediatric Intensive Care Audit Network (PICANet)[18] is a national clinical audit that receives
demographic and clinical data on all admissions to PICUs in the UK and the Republic of Ireland. Data
collection started in England and Wales in 2002. Diagnostic and procedure information is coded in
PICANet using Clinical Terms 3 (The Read Codes). Hospital Episode Statistics (HES) is a hospital
admission database, comprising all hospital admissions paid for by the National Health Service (NHS)
in England.[19] Diagnoses in HES are recorded using the International Classification of Diseases
version 10 (ICD-10). Each child recorded in PICANet was linked to their longitudinal HES admission
record (since April 1997) by the HES data providers (NHS Digital) using a deterministic algorithm
based on NHS number, date of birth, sex and postcode.
4Study population
We extracted data on all influenza-related admissions to PICUs in England for resident children aged
less than 16 years between October 2003 and March 2015. An influenza-related admission was
defined as a PICU admission in PICANet where either a) any of the diagnostic fields included an
influenza-related Read code (see Supplementary Table S1), or b) a linked hospital admission starting
up to 7 days before or three days after a PICANet admission had an ICD-10 code indicating influenza
(J09-J11). Readmissions to PICU within 12 hours of discharge from a previous admission in the same
unit were excluded, to allow for children being discharged and readmitted in case of surgery. We
defined the winter season as 1st October in year x to end of March in year x+1.
Outcomes
The primary outcome in this study was mortality during PICU admission. The secondary outcomes
were type of ventilation and requirement for vasoactive drugs. Data on these outcomes were
recorded in PICANet. Where a child died during a readmission within 12 hours of the previous
(index) admission, the mortality outcome was applied to the index admission (and the readmission
excluded). Type of ventilation was coded into a three-category variable: no ventilation, non-invasive
ventilation (including high-flow nasal oxygen and continuous positive airway pressure) and invasive
ventilation (endotracheal intubation or tracheostomy). For the statistical models, we collapsed the
no ventilation and non-invasive ventilation categories to derive a binary variable: invasive ventilation
and no invasive ventilation. Requirement for vasoactive drugs was coded into a binary variable
(yes/no).
Risk factors
We hypothesised, based on previous literature, that age, gender and presence of high-risk
conditions would be associated with severe influenza symptoms, including invasive ventilation[7, 20,
21], and that severe outcomes would vary over time, particularly between pandemic and non-
pandemic seasons. We examined whether a child’s ethnic group and socio-economic status were
also associated with mortality, or need for invasive ventilation and vasoactive drugs.
Age was derived from PICANet records and coded into a four category variable (<6 months, 6-<24
months, 2-<5 years, 5-<16 years), using standard age groups for influenza surveillance, but splitting
the youngest age groups according to current eligibility to receive influenza vaccine in the UK.[22,
23] Sex was derived from PICANet, or if missing, from the child’s linked HES record.
Ethnic group was determined from the PICANet record, or if missing, from a child’s longitudinal HES
record prior to PICANet admission. The ethnic group classification in PICANet and HES maps onto
2011 Census categories.[24] We coded ethnic group into a four category variable to ensure sufficient
numbers for analysis: white (including white British, white Irish and other white), mixed or multiple
ethnic groups, Asian or Asian British (including Indian, Pakistani, Bangladeshi, Chinese or other
Asian), black or black British (including black Caribbean, black African and black other), and other
ethnic groups.
Socio-economic status was estimated using the Index of Multiple Deprivation (IMD),[25] a small
area-level (between 1000 and 3000 people) based classification of material deprivation. The IMD
score was available from the longitudinal HES record, mapped from the child’s residential postcode,
and coded into quintiles. We assigned a PICANet admission to the IMD quintile recorded during the
hospital episode nearest in time to the PICANet admission date.
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vaccination under the targeted programme using a previously published Read code list[26] which
has been translated into ICD-10 codes.[27, 28] We searched for the relevant Read codes during the
PICANet admission or for the corresponding ICD-10 codes during the child’s longitudinal HES records
at any time before PICANet admission. The conditions were classified into six groups to ensure
sufficient numbers for analysis: neurological, respiratory, cardiovascular conditions,
immunodeficiency, kidney conditions or diabetes, and liver conditions or obesity. For the statistical
models, we used a binary indicator: presence of a high-risk condition: yes/no.
We defined five time periods to examine changes over time in the probability of each outcome:
October 2003-March 2009 (pre-pandemic period), April 2009-March 2010 (pandemic waves 1 and
2), April 2010-March 2011 (pandemic wave 3), April 2011-August 2013 (post-pandemic period) and
September 2013-March 2015 (roll out of universal paediatric influenza vaccination programme).
Statistical analyses
We estimated the number of admissions and influenza-related PICU admission rates during winter
seasons per 100,000 children by sex and age group. Denominators were derived from mid-year
population estimates from the Office for National Statistics.[29] We combined admissions for
children under two years of age since denominator populations for children aged <6 months were
not available.
We determined the proportion of admitted children with a high-risk condition, and the proportion of
deaths in PICU where the child had a high-risk condition. To examine risk factors for mortality during
PICU admission, we fitted mixed effects logistic regression models with death as the outcome
variable, and unit as the random effect. We included unit as a random effect since outcomes within
units have been shown to be more similar than across units [30, 31], due to differences in the case-
mix of children admitted, as well as differences in care practices. Age group, gender, presence of
high-risk conditions and time period were included in the baseline model a priori. We added ethnic
group and IMD quintile in a forward stepwise fashion. Model fit was compared using the Akaike
Information Criterion (AIC). Admissions with missing values for any of the outcomes or risk factors
were excluded. We repeated the modelling process for the outcomes ventilation type and
requirement for vasoactive drugs.
Ethical approval
Collection of personally identifiable data has been approved by the Patient Information Advisory
Group (now the NHS Health Research Authority Confidentiality Advisory Group-CAG) see -
http://www.hra.nhs.uk/documents/2017/04/cag-piag-register-march-2017.xls - and ethics
approval granted by the Trent Medical Research Ethics Committee, ref. 05/MRE04/17 +5. The CAG
and ethics approvals cover linkage between PICANet and other databases, including HES.
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We identified 1961 influenza-related PICU admissions in 1778 children to 31 PICUs. 1628 children
had one influenza-related PICU admission (91.6%), 123 children (6.9%) had two and 27 children had
three or more (1.5%). Of the 183 readmissions, 171 (93.4%) occurred within six months of the first
admission.
Of the 1961 admissions, 20.7% (406 admissions) were identified as influenza-related admissions
from PICANet only, 52.8% (1035 admissions) from hospital admission records only, and 26.5% (520
admissions) could be identified from both data sources. Of the 926 admissions identified from PICU
records, 95.8% (887 admissions) were linked to at least one preceding hospital record. 26% of
influenza-related PICU admissions were in infants aged less than six months old (Table 1), and 56%
were in children less than two years old.
1540 admissions were in children with at least one high-risk condition (78.5%); and 63.5% of these
were among children with high-risk conditions from more than one of the six groups of conditions
(978 admissions). Respiratory and neurological conditions were the most common types of high-risk
conditions among admitted children. The proportion of children with high-risk conditions increased
with age. Among children aged six months to less than two years old, 452 of 589 admissions were in
children with high-risk conditions (76.7%), increasing to 473 of 514 admissions (92.2) in children
aged 5-15 years.
The crude admission rate was 2.6/100,000 children during winter seasons (95% CI 2.4, 2.7). Boys had
significantly higher admission rates than girls: 2.9 (2.7, 3.1) versus 2.3 (2.1, 2.4). Age-specific rates
were 10.5 (9.8, 11.3) among <2 year olds, 2.6 (2.3, 2.9) among 2-<5 year olds and 1.0 (0.9, 1.1)
among 5-<16 year olds. In the four seasons since the end of the influenza pandemic, 138 children
were admitted to PICU with influenza on average each season.
7Table 1: Distribution of risk factors among admitted children (n=1961)
Risk factor Number (%)
Sex
Male 1132 (57.7)
Female 829 (42.3)
Age group
<6 months 509 (26.0)
6-<24 months 589 (30.0)
2-<5 years 349 (17.8)
5-<16 years 514 (26.2)
Presence of high-risk condition
No 421 (21.5)
Yes 1540 (78.5)
Type of high-risk condition*
Neurological conditions 931 (47.5)
Respiratory conditions 969 (49.4)
Heart conditions 746 (38.0)
Immunodeficiency 200 (10.2)
Kidney conditions or diabetes 175 (8.9)
Liver conditions or obesity 182 (9.3)
Time period
October 2003-March 2009
(Pre-pandemic)
487 (24.8)
April 2009-March 2010
(Pandemic, waves 1 & 2)
375 (19.1)
April 2010-March 2011
(Pandemic Wave 3)
371 (18.9)
April 2011-August 2013
(Post-pandemic)
367 (18.7)
September 2013-March 2015
(Universal paediatric influenza
vaccination programme)
361 (18.4)
Ethnic group
White 1315 (67.1)
Mixed/multiple 53 (2.7)
Asian/Asian British 331 (16.9)
Black/black British 169 (8.6)
Other 51 (2.6)
Missing 42 (2.1)
Index of Multiple Deprivation quintile
1st Most deprived 677 (34.5)
2nd 416 (21.2)
3rd 338 (17.2)
4th 222 (11.3)
5th Least deprived 267 (13.6)
Missing 41 (2.1)
Total 1961
*The number of children with each high-risk condition adds up to more than 1961 since children can have multiple
conditions
8Risk factors for mortality (primary outcome)
Overall, 143 admissions ended in death (7.3%). Only 3.5% of all deaths (n=5) were in children
without high-risk conditions; these were not concentrated in any year or in any age group. The odds
of mortality was over nine times higher for children with high-risk conditions (Table 2). Girls, and
children from Asian/Asian British or other non-majority ethnic groups, apart from black/black British
also experienced significantly higher odds of dying during admission. The odds of mortality was
significantly increased before and during the pandemic compared to the post-pandemic period.
9Table 2 Percentage of children who died during PICU admission, and crude and adjusted* odds
ratios from logistic regression models, by risk factor (n=1886)
Risk factor Died during admission n
(% of children in group)
Crude odds ratio (95%
CI)
Adjusted odds ratio
(95% CI)
Sex
Male 60 (5.3) 1 1
Female 83 (10.0) 1.98 (1.38, 2.85) 1.91 (1.31, 2.79)
Age group
<6 months 23 (4.5) 0.51 (0.27, 0.96) 0.82 (0.45, 1.49)
6-<24 months 34 (5.8) 1 1
2-<5 years 25 (7.2) 0.78 (0.45, 1.36) 1.29 (0.73, 2.29)
5-<16 years 61 (11.9) 1.66 (1.00, 2.76) 1.77 (1.09, 2.88)
Presence of high-risk condition
No 5 (1.2) 1 1
Yes 138 (9.0) 11.49 (3.63, 36.42) 9.57 (2.98, 30.73)
Time period
October 2003-March 2009
(Pre-pandemic)
38 (7.8) 2.11 (1.11, 4.03)
2.36 (1.22, 4.59)
April 2009-March 2010
(Pandemic, waves 1 & 2)
39 (10.4) 3.21 (1.69, 6.08)
2.95 (1.52, 5.73)
April 2010-March 2011
(Pandemic Wave 3)
36 (9.7) 2.87 (1.49, 5.51)
3.33 (1.69, 6.54)
April 2011-August 2013 (Post-
pandemic)
18 (4.9) 1
1
October 2013-March 2015
(Universal paediatric influenza
vaccination programme)
12 (3.3) 0.84 (0.37, 1.89) 0.79 (0.35, 1.81)
Ethnic group
White 76 (5.8) 1 1
Mixed/multiple 5 (9.4) 1.51 (0.52, 4.36) 1.75 (0.58, 5.31)
Asian/Asian British 46 (13.9) 2.55 (1.68, 3.88) 2.70 (1.74, 4.20)
Black/black British 4 (2.4) 0.39 (0.14, 1.10) 0.39 (0.14, 1.14)
Other 8 (15.7) 3.29 (1.45, 7.47) 3.95 (1.65, 9.42)
IMD quintile**
1st, Most deprived 52 (7.7) 1.27 (0.69, 2.34)
2nd 34 (8.2) 1.46 (0.77, 2.76)
3rd 21 (6.2) 1.09 (0.54, 2.17)
4th 13 (5.9) 0.95 (0.43, 2.09)
5th, Least deprived 16 (6.0) 1
*Adjusted for all other variables in model
**IMD quintile did not significantly improve the model fit and was therefore excluded from the final model.
10
Risk factors for invasive ventilation and need for vasoactive drugs (secondary outcomes)
Overall, 156 admissions (8.0 %) involved non-invasive ventilation only, and 1588 admissions (81.0%)
required invasive ventilation (Supplementary Table S2). Only 10.8 % (212 admissions) did not require
any form of respiratory support. Type of ventilation was unknown for five admissions. Age group,
sex, presence of high-risk conditions, ethnic group and time period were included in the final model
for invasive ventilation (Table 3). The presence of a high-risk condition was not significantly
associated with the odds of invasive ventilation. The probability of invasive ventilation was
significantly decreased during the first wave of the pandemic, and during the period since
September 2013 compared to the immediate post-pandemic period.
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Table 3 Crude and adjusted* odds ratios for invasive ventilation from logistic regression models,
by risk factor (n=1882)
Risk factor Crude odds ratio
(95% CI)
Adjusted odds ratio
(95% CI)
Sex
Male 1 1
Female 0.75 (0.58, 0.96) 0.76 (0.59, 0.98)
Age group
<6 months 1.09 (0.74, 1.61) 1.00 (0.67, 1.49)
6-<24 months 1 1
2-<5 years 1.00 (0.69, 1.44) 0.96 (0.67, 1.40)
5-<16 years 0.82 (0.56, 1.20) 0.84 (0.57, 1.24)
Presence of high-risk conditions
No 1 1
Yes 0.73 (0.53, 1.01) 0.77 (0.55, 1.07)
Time period
October 2003-March 2009 (Pre-pandemic) 0.73 (0.49, 1.10) 0.72 (0.48, 1.08)
April 2009-Mach 2010 (Pandemic, waves 1 & 2) 0.53 (0.35, 0.80) 0.54 (0.36, 0.82)
April 2010-March 2011 (Pandemic Wave 3) 0.94 (0.61, 1.45) 0.89 (0.57, 1.38)
April 2011-August 2013 (Post-pandemic) 1 1
Universal paediatric influenza vaccination programme 0.6 (0.40, 0.91) 0.58 (0.38, 0.87)
Ethnic group
White 1 1
Mixed/multiple 1.21 (0.54, 2.71) 1.27 (0.56, 2.89)
Asian/Asian British 1.09 (0.77, 1.55) 1.17 (0.82, 1.67)
Black/black British 0.58 (0.38, 0.87) 0.59 (0.38, 0.89)
Other 0.77 (0.37, 1.59) 0.75 (0.36, 1.56)
IMD quintile**
1st, Most deprived 0.90 (0.60, 1.34)
2nd 1.22 (0.79, 1.88)
3rd 1.22 (0.78, 1.92)
4th 1.18 (0.70, 1.96)
5th, Least deprived 1
*Adjusted for all other variables in model
**IMD quintile did not significantly improve the model fit and was therefore excluded from the final model.
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Children received vasoactive drugs in 586 admissions (29.9%). Information on vasoactive drugs was
missing for 40 admissions. Use of vasoactive drugs increased with age, and with presence of high-risk
conditions. Children with immunodeficiency were most likely to be treated with vasoactive drugs.
(Supplementary Table S3, Table 4). Girls were significantly more likely than boys to be given
vasoactive drugs, even after adjustment for age and high-risk conditions. Compared to the post-
pandemic period, use of vasoactive drugs was significantly lower during the period after the
introduction of universal influenza vaccination.
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Table 4. Crude and adjusted* odds ratios for requirement for vasoactive drugs from logistic
regression models, by risk factor (n=1850)
Risk factor Crude odds ratio
(95% CI)
Adjusted odds ratio
(95% CI)
Sex
Male 1 1
Female 1.44 (1.16, 1.77) 1.40 (1.12, 1.73)
Age group
<6 months 0.57 (0.41, 0.81) 0.64 (0.45, 0.91)
6-<24 months 1 1
2-<5 years 0.94 (0.69, 1.28) 0.94 (0.68, 1.29)
5-<16 years 1.70 (1.24, 2.31) 1.52 (1.10, 2.08)
Presence of high-risk condition
No 1 1
Yes 2.58 (1.89, 3.51) 2.18 (1.58, 3.01)
Time period
October 2003-March 2009
(Pre-pandemic)
0.75 (0.54, 1.04) 0.79 (0.57, 1.11)
April 2009-Mach 2010
(Pandemic, waves 1 & 2)
1.12 (0.81, 1.55) 1.00 (0.71, 1.40)
April 2010-March 2011
(Pandemic Wave 3)
1.22 (0.88, 1.69) 1.28 (0.91, 1.80)
April 2011-August 2013
(Post-pandemic)
1 1
Universal paediatric influenza
vaccination programme
0.59 (0.41, 0.84) 0.59 (0.41, 0.84)
Ethnic group**
White 1
Mixed/multiple 0.69 (0.34, 1.38)
Asian/Asian British 1.31 (0.98, 1.75)
Black/black British 0.93 (0.62, 1.38)
Other 1.22 (0.62, 2.39)
Index of Multiple Deprivation
(2004) quintile**
1st Most deprived 0.86 (0.61, 1.21)
2nd 0.87 (0.61, 1.24)
3rd 1.02 (0.70, 1.47)
4th 0.93 (0.62, 1.40)
5th Least deprived 1
*Adjusted for all other variables in model
**Ethnic group and Index of Multiple Deprivation quintile did not significantly improve the fit of the
final model and was therefore not included.
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Discussion
There are around 140 influenza-related PICU admissions every year in England. Over three quarters
of children with an influenza diagnosis admitted to PICU had high-risk conditions and a quarter of
admissions occurred in children aged less than six months old who are too young to be vaccinated.
Children admitted to PICU with influenza were more likely to be boys; and boys were significantly
more likely to survive. Older children, and children from an Asian or other ethnic group also had
significantly higher odds of mortality even after adjustment for high-risk conditions.
This is the largest UK study to date of severe influenza infections in children resulting in PICU
admission. Linkage between PICU and the national hospital admission database improved the
ascertainment of high-risk conditions: the proportion of admitted children with high-risk conditions
was over 50% higher when using data from linked longitudinal hospital records compared to using
intensive care data alone. This underrecording arises since some PICUs tend to report the main
reason for admission to PICU only. Linkage between PICU and hospital admission data also allowed
more influenza-related PICU admissions to be identified, thus avoiding the low sensitivity of
diagnostic coding for specific respiratory infections.[32] National data collection over several years
was required to estimate relative odds of mortality according to key risk factors, since influenza-
related deaths in children are rare.
Our study also had some weaknesses. First, we did not have access to data on laboratory
confirmation of influenza infection. There is no national testing protocol for children presenting to
hospital with symptoms of respiratory infections in England. However, we note that the average
number of PICU admissions in children aged 0-14 years in this study between weeks 40 and 12 in the
2013/14 and 2014/15 influenza seasons is similar to the number published by Public Health England
through the USISS surveillance scheme which only includes laboratory confirmed influenza (although
the USISS scheme also covers higher dependency units).[33, 34]
Second, influenza vaccination history is not recorded on PICANet nor HES, and there is currently no
national immunisation database anywhere in the UK which captures influenza vaccination in
children. We could therefore not estimate the proportion of children admitted to PICU with
influenza who had been vaccinated. Similarly, data on antiviral use was not available in PICANet, nor
in HES.
Third, we used an extract of linked hospital admission records for children who had had at least one
PICU admission. Therefore, we could not estimate the proportion of children admitted to hospital
with influenza who were admitted to PICU. Linkage between PICANet and a whole-nation birth
cohort created using longitudinal HES data for all children born in England[35] could be used to
examine the impact of the introduction of the universal paediatric influenza vaccination policy on
children with specific high-risk conditions.
Children with high-risk conditions accounted for over 75% of influenza-related PICU admissions, and
83.5% among admissions in children aged over six months old. These children also accounted for
97% of the deaths. A previous UK study conducted during the 2009 pandemic based on death
certification data and clinician reports found that two thirds of deaths were in children with high-risk
conditions.[21] In contrast, a study of PICU admissions in Australia and New Zealand 2007-2013
found that 59% of admissions were in previously healthy children.[36]. However this study was
based on PICU reports only and high-risk conditions may have been under-recorded, emphasising
the value of linking intensive care audit to hospital admission data. Influenza vaccination has been
found to reduce the risk of PICU admission in an observational case-negative control study
conducted in the United States.[37] Influenza vaccine uptake in England among children with high-
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risk conditions has remained below 30% for children aged 6 months to less than two years, and
below 50% for children aged 2-15 years since 2009/10. The low uptake has been linked to concerns
about vaccine safety and parental views of influenza as a less serious illness, as well as difficulties
accessing vaccination services.[14] Increasing the burden of influenza on PICUs should therefore
focus on increasing vaccination uptake among children with high-risk chronic conditions, particularly
among children aged between six months and two years who have the lowest uptake, and higher
PICU admission rates than older children. Children aged less than six months accounted for 26% of
PICU admissions. Since there are no influenza vaccines licensed for this age group, alternative
strategies including maternal vaccination during pregnancy,[38] and sibling vaccination[28] are likely
to reduce the burden of influenza among this age group.
Children from an Asian/Asian British or other non-majority ethnic background were more likely to be
admitted to PICU with an influenza-related infection and more likely to die after admission. The
increased odds of mortality remained, even after adjusting for the presence of high-risk conditions.
Previous studies have also identified an increased risk of death in children from an Asian ethnic
group following PICU admission.[39, 40] The type and severity of comorbidities could be different in
children from non-majority ethnic groups. A study using a national birth cohort of children with
specific high-risk conditions linked to PICANet data is required to determine if this is the case.
Further, we found that girls were significantly more likely than boys to die after admission, despite
higher PICU admission rates in boys. Girls were also more likely to require vasoactive drugs, but less
likely to require invasive ventilation. A higher mortality rate in girls was also found among children
admitted to PICUs in the United States during the pandemic 2009/10 season,[41] and among all
PICANet admissions,[31] although the increased odds of mortality for girls among all PICANet
admissions was significantly lower than in this study. Other case series of childhood influenza deaths
(irrespective of PICU admission) have had a more even sex distrbution.[21, 42] A whole-country
birth cohort linked to PICANet and a national hospital admission database would be required to
determine whether the increased mortality rate in girls could be explained by a higher proportion of
boys dying before PICU admission.
Mortality among admitted children was significantly higher before and during the H1N1 pandemic
compared to the four seasons following the pandemic, even after adjustment for age and the
presence of high-risk conditions. Higher mortality rates for pandemic, compared to seasonal,
influenza in children were also reported in Argentina in 2009/10.[43] In contrast, a multi-centre
study in Canada reported no significant difference between mortality rates among children
hospitalised during pre-pandemic and pandemic influenza periods.[44] Overall mortality in PICUs in
the UK and Ireland have decreased since 2003 when PICANet data collection began.[30] The
decreased mortality observed in the seasons since 2009/10 in our study may also be explained by
variation over time in case detection and the recording of underlying high-risk conditions. We found
a significantly decreased risk of invasive ventilation during the first two waves of the pandemic and
in the last two seasons of the study (2013/14 and 2014/15) compared to the two immediate post-
pandemic winters (2011/12 and 2012/13). Therefore, admission thresholds may also have varied
across the study period. Follow-up studies are required to determine whether the decline in
mortality among children with influenza in PICU observed since the end of the pandemic is
maintained over subsequent seasons.
Conclusions
Infants and children with high-risk conditions account for three quarters of influenza-associated
admissions to PICU Increasing influenza vaccination uptake among children with high-risk conditions
is therefore needed to decrease the influenza burden on PICUs. Further research, based on linkage
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between PICANet records and a national birth cohort of children created using administrative
databases, is required to explain mortality differences among admitted children according to sex and
ethnic group.
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Highlights
 79% of influenza-related PICU admissions were in children with high-risk chronic conditions
 7.3% of admissions ended in death for the admitted child
 Girls admitted to PICU with influenza had almost twice the odds of dying compared to boys
 Mortality as significantly higher before and during the A(H1N1)pdm 2009 pandemic
compared to the post-pandemic period
1Supplementary material
Table S1. Read codes used to identify children with influenza in PICANet data
Admissions with codes with an asterisk (*) recorded were only classified as an influenza-related
admission either if another non-asterisked code was also recorded, or there was no mention of
another viral or bacterial infection listed in Part B of Table S1 below.
Part A: Read codes indicating influenza infection
Read code Description
65E.. Influenza vaccination
eiX4. Tamiflu 12mg/mL oral suspension
H27.. Influenza
H270. Influenzal pneumonia
H2700 Influenza with bronchopneumonia
H2701 Influenza with pneumonia, influenza virus identified
H270z Influenza with pneumonia NOS
H271. Influenza with other respiratory manifestation
H2710 Influenza with laryngitis
H271z Influenza with respiratory manifestations NOS
H27y. Influenza with other manifestations
H27y0 Influenza with encephalopathy
H27yz Influenza with other manifestations NOS
Hyu04 [X]Flu+oth respiratory manifestations,'flu virus identified
Hyu05 [X]Influenza+other manifestations,influenza virus identified
Hyu07 [X]Influenza with other manifestations, virus not identified
X001O Post-influenza encephalitis
X73lf Influenza virus
X73lh Influenza virus A
X73li Influenza virus B
XA1Lu influenza A virus
Xa9J7 H1N1
XaC1s Encephalitis due to influenza
XaC2H Encephalitis due to influenza-virus identified
XaFue Influenza B antibody level
XaILu Influenza A antigen level
XaILv Influenza B antigen level
XaPIN Influenza H1 virus detected
XaPIP Influenza H3 virus detected
XaQQp Influenza due to Influenza A virus subtype H1N1
XE0YK Influenza NOS
XM0rz Influenza-like illness
XM0s0 Flu-like illness NOS
H2... Pneumonia and influenza*
H2y.. Other specified pneumonia or influenza*
H2z.. Pneumonia or influenza NOS*
Part B: Read codes indicating other viral and bacterial infection
A0762 Enteritis due to rotavirus
2A0762 Enteritis due to rotavirus
A3B5. Haemophilus influenzae infection
A42.. Enteroviral meningitis
A795. Coronavirus infection
A796. Parvovirus infection
AyuDB [X]Enterovirus infection, unspecified
AyuKC [X]H influenzae as cause/diseases classified/other chapters
F0305 Mumps encephalitis
F0350 Varicella encephalitis
H0608 Acute haemophilus influenzae bronchitis
H060C Acute parainfluenza virus bronchitis
H060D Acute respiratory syncytial virus bronchitis
H060E Acute bronchitis due to rhinovirus
H0615 Acute bronchiolitis due to respiratory syncytial virus
H0616 Acute bronchiolitis due to other specified organisms
H200. Adenoviral pneumonia
H201. Pneumonia due to respiratory syncytial virus
H202. Parainfluenzal pneumonia
H222. Haemophilus influenzae pneumonia
H243. Pertussis pneumonia
SLJ6. Pertussis, including combinations, vaccine poisoning
X000j Enteroviral encephalitis
X100D Acute bronchiolitis due to adenovirus
X30BS Rotavirus gastroenteritis
X30BT Norwalk virus gastroenteritis
X70Li Enteroviral infection
X73kR Rotavirus
X73lE Coronavirus
X73lK Parainfluenza virus type 1
X73lM Parainfluenza virus type 3
X73lN Parainfluenza virus type 4
X73Rb Haemophilus influenzae
Xa0BK Respiratory syncytial virus infection
Xa8VO Parainfluenza virus
XaIbN Parainfluenza virus antibody level
XaIdE Parainfluenza type 3 antibody level
XaJLY Enterovirus ribonucleic acid detection
XaLTa RSV nucleic acid detection
XaLTL Human metapneumovirus nucleic acid detection
XaPOd Human metapneumovirus detected
XaREr Enteritis due to norovirus
XE0Qw Whooping cough
XE0R9 Varicella infection
XE2uH Adenovirus infection
XE2uI Rhinovirus infection
XSCDz Haemophilus infection
3Table S2: Number (%) of admissions according to type of ventilation and risk factor (n=1956)
Risk factor Not ventilated Non-invasive ventilation only Invasive ventilation
Sex
Male 114 (10.1) 79 (7.0) 936 (82.9)
Female 98 (11.9) 77 (9.3) 652 (78.8)
Age group
<6 months 42 (8.3) 41 (8.1) 426 (83.7)
6-<24 months 73 (12.4) 43 (7.3) 471 (80.2)
2-<5 years 42 (12.1) 21 (6.0) 285 (81.9)
5-<16 years 55 (10.7) 51 (10) 406 (79.3)
Presence of chronic condition
No 37 (8.8) 30 (7.2) 352 (84.0)
Yes 175 (11.4) 126 (8.2) 1236 (80.4)
Ethnic group
White 130 (9.9) 100 (7.6) 1083 (82.5)
Mixed/multiple 5 (9.4) 3 (5.7) 45 (84.9)
Asian/Asian British 37 (11.3) 26 (7.9) 266 (80.9)
Black/black British 29 (17.2) 20 (11.8) 120 (71.0)
Other or missing* 11 (12.0) 7 (7.6) 74 (80.4)
Time period
October 2003-March 2009 (Pre-pandemic) 52 (10.8) 30 (6.2) 400 (83.0)
April 2009-Mach 2010 (Pandemic, waves 1 & 2) 66 (17.6) 23 (6.1) 286 (76.3)
April 2010-March 2011 (Pandemic Wave 3) 31 (8.4) 28 (7.6) 312 (84.1)
April 2011-August 2013 (Post-pandemic) 26 (7.1) 31 (8.5) 310 (84.5)
Universal paediatric influenza vaccination programme 37 (10.3) 44 (12.2) 280 (77.6)
4Index of Multiple Deprivation (2004) quintile
1st Most deprived 83 (12.3) 66 (9.8) 527 (78.0)
2nd 46 (11.1) 25 (6.0) 344 (82.9)
3rd 30 (8.9) 27 (8.0) 280 (83.1)
4th 17 (7.7) 18 (8.2) 185 (84.1)
5th Least deprived or missing 36 (11.7) 20 (6.5) 252 (81.8)
Total 212 (10.8) 156 (8.0) 1588 (81.2)
Type of chronic condition
Neurological conditions 91 (9.8) 86 (9.3) 751 (80.9)
Respiratory conditions 101 (10.4) 95 (9.8) 772 (79.8)
Heart conditions 82 (11.0) 69 (9.3) 595 (79.7)
Immunodeficiency 40 (20.0) 15 (7.5) 145 (72.5)
Kidney conditions or diabetes 32 (18.3) 15 (8.6) 128 (73.1)
Liver conditions or obesity 18 (9.9) 13 (7.1) 151 (83.0)
*Total number adds up to more than 1956 since a child can have multiple chronic conditions
**Missing group is not presented separately due to small number of admissions with missing values
5Table S3: Characteristics of children whose PICU admission required vasoactive drugs
Risk factor Treated with vasoactive drugs n (% of all
children in group)*
Sex
Male 308 (27.8)
Female 278 (34.2)
Age group
<6 months 104 (20.6)
6-<24 months 164 (28.6)
2-<5 years 103 (30.5)
5-<16 years 215 (42.5)
Presence of chronic condition
No 68 (16.6)
Yes 518 (34.3)
Time period
October 2003-March 2009 (Pre-pandemic) 124 (27.7)
April 2009-Mach 2010 (Pandemic, waves 1 & 2) 128 (34.1)
April 2010-March 2011 (Pandemic Wave 3) 133 (35.9)
April 2011-August 2013 (Post-pandemic) 121 (33.0)
Universal paediatric influenza vaccination programme 80 (22.2)
Ethnic group
White 392 (30.4)
Mixed/multiple 13 (24.5)
Asian/Asian British 111 (34.4)
Black/black British 47 (27.8)
Other 14 (28.6)
Missing 9 (23.7)
Index of Multiple Deprivation quintile
1st Most deprived 189 (28.2)
2nd 119 (29.3)
3rd 105 (31.9)
4th 69 (32.1)
5th Least deprived 83 (32.1)
Missing 21 (51.2)
Total 586 (30.5)
Type of chronic condition*
Neurological conditions 318 (34.9)
Respiratory conditions 319 (33.4)
Heart conditions 279 (37.8)
Immunodeficiency 81 (40.7)
Kidney conditions or diabetes 72 (41.9)
Liver conditions or obesity 71 (39.0)
*The denominator excludes the 40 admissions where need for vasoactive drugs was missing
